EUVIMEDEUVIMED entdecken
Crossref

Myeloid CD38 deficiency ameliorates sepsis-induced cardiomyopathy by alleviating inflammatory response through the SIRT1/NF-κB/NLRP3 pathways

Qi Ding, Jia-Hui Li, Ze-Yu Hu, Shi-Yue Jiang, Xin-Yu Yu, Qi-Hang Zhao, Ke Wen, Hao-Cheng Gu, Yi-Kai Wang, Yun-Fei Xiao, Xiao-Hui Guan, Ling-Fang Wang

International Immunopharmacology · 2026-10 · 186 · 117157

DOI: 10.1016/j.intimp.2026.117157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-10. Verfasst von Qi Ding und 11 weiteren Autor:innen. Beteiligte Einrichtung: The National Engineering Research Center for Bioengineering Drugs and the Technologies, Jiangxi Province Key Laboratory of Bioengineering Drugs, Inst…. Hauptthemen laut MEDLINE: ADP-ribosyl Cyclase 1, Sepsis, Sirtuin 1, Cardiomyopathies. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Jiangxi Provincial Natural Science Foundation, Nanchang University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Sepsis-induced cardiomyopathy (SICM) is a life-threatening complication with limited therapeutic options. Macrophage-driven inflammation and pyroptosis are central to SICM pathogenesis, but the role of myeloid CD38, the primary NAD+ hydrolase, in SIC remains unexplored. METHODS: Myeloid-specific CD38 knockout (CD38ᴹᴷᴼ) mice and CD38ᶠˡ°ˣ controls were subjected to cecal ligation and puncture (CLP) to induce sepsis. Cardiac function, myocardial inflammation, pyroptosis, and oxidative stress were assessed. Bone marrow-derived macrophages (BMDMs) and conditioned medium studies were used to investigate mechanisms and paracrine effects on cardiomyocytes. RESULTS: CD38 was upregulated in cardiac macrophages of septic mice. Myeloid CD38 deletion improved cardiac function, reduced injury markers, and attenuated myocardial inflammation, pyroptosis, and oxidative stress. CD38ᴹᴷᴼ mice exhibited reduced M1 and enhanced M2 macrophage polarization. CD38-deficient BMDMs showed suppressed NF-κB activation, NLRP3 inflammasome assembly, and glycolysis-related gene expression (HIF1α, SLC2A1), with concomitant NAD+ accumulation and SIRT1 upregulation. SIRT1 inhibition reversed these protective effects. Conditioned medium from CD38ᴹᴷᴼ macrophages protected cardiomyocytes from oxidative injury. Proteomic analysis revealed enrichment of mitochondrial proteins in the CD38-deficient macrophage secretome. CONCLUSIONS: Myeloid CD38 deficiency protects against SIC by activating the SIRT1/NF-κB/NLRP3 axis, promoting M2 polarization, suppressing pyroptosis, and remodeling the macrophage secretome. Targeting myeloid CD38 represents a promising therapeutic strategy for SICM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADP-ribosyl Cyclase 1SepsisSirtuin 1CardiomyopathiesMacrophagesAnimalsNLR Family, Pyrin Domain-Containing 3 ProteinMice, KnockoutNF-kappa BSignal TransductionMiceMaleMice, Inbred C57BLMyocytes, CardiacOxidative StressInflammasomesPyroptosisMembrane Glycoproteins

Stichwörter der Autor:innen

CD38MacrophagesPyroptosisSIRT1Sepsis-induced cardiomyopathy

Substanzen

ADP-ribosyl Cyclase 1NLR Family, Pyrin Domain-Containing 3 ProteinSirtuin 1Cd38 protein, mouseNlrp3 protein, mouseSirt1 protein, mouseNF-kappa BInflammasomesMembrane Glycoproteins

Autor:innen und Institutionen

  • The National Engineering Research Center for Bioengineering Drugs and the Technologies, Jiangxi Province Key Laboratory of Bioengineering Drugs, Institute of Translational Medicine, Jiangxi Medical College, Nanchang Uni…

Förderung

  • Jiangxi Provincial Natural Science Foundation
  • Nanchang University
  • National Natural Science Foundation of China

Zitieren

APA

Ding, Q., Li, J. H., Hu, Z. Y., Jiang, S. Y., Yu, X. Y., Zhao, Q. H., Wen, K., Gu, H. C., Wang, Y. K., Xiao, Y. F., Guan, X. H., & Wang, L. F. (2026). Myeloid CD38 deficiency ameliorates sepsis-induced cardiomyopathy by alleviating inflammatory response through the SIRT1/NF-κB/NLRP3 pathways. International Immunopharmacology, 186, 117157. https://doi.org/10.1016/j.intimp.2026.117157

Vancouver

Ding Q, Li JH, Hu ZY, Jiang SY, Yu XY, Zhao QH, et al. Myeloid CD38 deficiency ameliorates sepsis-induced cardiomyopathy by alleviating inflammatory response through the SIRT1/NF-κB/NLRP3 pathways. International Immunopharmacology. 2026;186:117157. doi:10.1016/j.intimp.2026.117157

BibTeX
@article{Ding2026,
  author = {Ding, Qi and Li, Jia-Hui and Hu, Ze-Yu and Jiang, Shi-Yue and Yu, Xin-Yu and Zhao, Qi-Hang and Wen, Ke and Gu, Hao-Cheng and Wang, Yi-Kai and Xiao, Yun-Fei and Guan, Xiao-Hui and Wang, Ling-Fang},
  title = {Myeloid CD38 deficiency ameliorates sepsis-induced cardiomyopathy by alleviating inflammatory response through the SIRT1/NF-κB/NLRP3 pathways},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {186},
  pages = {117157},
  doi = {10.1016/j.intimp.2026.117157}
}
Kostenlos starten →